FindTrial
Sign In

Study on the value of dynamic changes of FT3 in hospitalized patients with COVID-19 pneumonia in optimizing critical care regimens

Study on the value of dynamic changes of FT3 in hospitalized patients with COVID-19 pneumonia in optimizing critical care regimens

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200061466
Enrollment
Unknown
Registered
2022-06-25
Start date
2022-06-13
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Combined with low T3 syndrome group:None
Group without low T3 syndrome:None

Sponsors

Shanghai Sixth People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
60 Years to 110 Years

Inclusion criteria

Inclusion criteria: Hospitalized patients aged >=60 years with COVID-19 infection.

Exclusion criteria

Exclusion criteria: Patients in hyperthyroidism / hypothyroidism treatment.

Design outcomes

Primary

MeasureTime frame
Free T3;—

Countries

China

Contacts

Public ContactJiang Fusong

Shanghai Sixth People's Hospital

hajfs@126.com+86 18930174732

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026